Precision medicine uses genetic data, biomarkers, and personalized diagnostics to tailor prevention and treatment to individual patients. While it improves accuracy, it also creates new legal risks for doctors, labs, and hospitals, such as:

• Failure to order or interpret genetic tests correctly
• Misuse of genomic databases or AI-based diagnostic tools
• Failure to warn patients (or relatives) about inherited risks
• Informed consent failures in gene therapy or genetic testing
• Laboratory errors in sequencing or variant interpretation

Courts generally treat these issues under medical negligence, informed consent, and duty to warn doctrines, even though “precision medicine” itself is still evolving legally.

Below are key landmark cases (5+), explained in detail, that form the backbone of liability principles relevant to precision medicine.

1. Canterbury v. Spence (1972, U.S. Court of Appeals, D.C. Circuit)

Core Issue:

Whether a doctor must disclose all material risks before treatment.

Facts:

A patient underwent spinal surgery and was not informed of the risk of paralysis. He became paralyzed and sued for negligence.

Judgment:

The court held that doctors must disclose all material risks that a reasonable patient would consider important before consenting.

Legal Principle:

• Established the modern doctrine of informed consent
• Shifted standard from “professional custom” to “patient-centered disclosure”

Relevance to Precision Medicine:

In genetic testing or gene therapy:

• Doctors must disclose risks of false positives/negatives
• Must explain uncertainty in genomic interpretation
• Must inform patients about incidental findings (e.g., cancer predisposition genes)

2. Helling v. Carey (1974, Washington Supreme Court)

Core Issue:

Whether a doctor can be negligent for failing to perform a low-cost diagnostic test not required by standard practice.

Facts:

An ophthalmologist failed to test a young patient for glaucoma because it was uncommon in her age group. She later became blind.

Judgment:

The court held the doctor liable despite following customary practice.

Legal Principle:

• Even if medical custom does not require a test, reasonable prudence may still require it
• Emphasized preventive diagnostics over professional norms

Relevance to Precision Medicine:

• Doctors may be liable for not ordering genetic screening when affordable and predictive
• Encourages early genomic testing in high-risk populations
• Supports liability for “missed prevention opportunities”

3. Pate v. Threlkel (1995, Florida Supreme Court)

Core Issue:

Whether a doctor has a duty to warn a patient’s relatives about hereditary disease risks.

Facts:

A patient with a genetic cancer syndrome was treated. The doctor informed the patient but did not directly warn her children, who later developed cancer.

Judgment:

The court held:

• Doctor’s duty is to warn the patient, not directly the relatives
• But warning must be sufficient so the patient can inform family members

Legal Principle:

• Establishes limited duty to warn in genetic contexts
• Balances patient confidentiality with genetic risk prevention

Relevance to Precision Medicine:

• Genetic information is inherently familial
• Raises liability if doctors fail to ensure patients understand family implications
• Important in BRCA mutations, Huntington’s disease, etc.

4. Safer v. Estate of Pack (1996, New Jersey Supreme Court)

Core Issue:

Expansion of duty to warn genetic relatives.

Facts:

A patient died of colon cancer linked to a hereditary condition. His daughter sued the physician for failing to warn her directly.

Judgment:

The court expanded liability by holding:

• Physicians may have a “duty to take reasonable steps” to warn at-risk relatives
• Does not necessarily require direct contact, but more proactive measures than just telling the patient

Legal Principle:

• Moves beyond Pate v. Threlkel
• Recognizes familial nature of genetic risk

Relevance to Precision Medicine:

• Supports stronger physician responsibility in genomic medicine
• Could justify structured family notification systems in genetic counseling
• Increases liability exposure for geneticists and hospitals

5. Becker v. Schwartz (1978, New York Court of Appeals)

Core Issue:

Wrongful birth claim due to failure in genetic counseling.

Facts:

Parents alleged doctors failed to properly inform them of risks of Down syndrome and failed to offer appropriate prenatal testing.

Judgment:

Court allowed wrongful birth claims, recognizing that negligent genetic counseling can lead to liability for “unwanted birth of a disabled child.”

Legal Principle:

• Medical professionals can be liable for failure to provide adequate prenatal genetic information
• Damages may include extraordinary care costs for the child

Relevance to Precision Medicine:

• Directly linked to prenatal genomic screening liability
• Emphasizes importance of accurate risk prediction and counseling
• High relevance to reproductive genetic technologies (NIPT, IVF screening)

6. Procanik v. Cillo (1984, New Jersey Supreme Court)

Core Issue:

Damages in wrongful birth / wrongful life context.

Facts:

A child born with congenital rubella syndrome sued (through guardian) claiming doctors failed to diagnose maternal infection during pregnancy.

Judgment:

• Court allowed recovery of special damages (medical costs) but not general damages for “life itself”

Legal Principle:

• Recognized limits of liability in genetic injury cases
• Distinguished between economic harm and philosophical “life damages”

Relevance to Precision Medicine:

• Important for gene therapy and prenatal diagnostics
• Defines boundaries of compensation in genetic harm cases
• Influences liability for sequencing errors or missed diagnoses

7. Greenberg v. Miami Children’s Hospital Research Institute (2003, U.S. District Court, Florida)

Core Issue:

Ownership and consent in genetic research (Canavan disease gene case).

Facts:

Researchers collected tissue samples from families to identify a gene for Canavan disease. The hospital later patented the gene without fully informing contributors.

Judgment:

Court allowed claims such as:

• Lack of informed consent
• Breach of fiduciary duty
• Misuse of biological materials

Legal Principle:

• Genetic material and data involve heightened consent obligations
• Patients/families retain moral and legal interests in genetic contributions

Relevance to Precision Medicine:

• Directly relevant to genomic databases and biobanking
• Raises liability for unauthorized use of genetic data
• Critical for AI-driven precision medicine platforms

Overall Legal Principles Emerging from These Cases

Across these rulings, courts consistently emphasize:

1. Expanded Informed Consent

Doctors must disclose not only treatment risks but also:

• Genetic uncertainty
• Familial implications
• Secondary findings

2. Duty to Warn (Limited but Expanding)

• Traditionally to patient only (Pate)
• Increasing recognition of family-based duty (Safer)

3. Liability for Failure of Prevention

• Not ordering tests (Helling) can be negligence
• Preventive genomics is becoming standard of care

4. Wrongful Birth / Genetic Counseling Liability

• Failure to inform about genetic risks can lead to damages claims (Becker, Procanik)

5. Genetic Data Governance Liability

• Unauthorized use of samples/data can trigger legal claims (Greenberg)